M.S.CONSULTANTS
Pages
Home
MORNING UPDATES
EQUITY CALLS
PROVISIONAL FIGURE
COMMODITY CALLS
CONTACT US
Monday, 1 February 2016
Ajanta Pharma Q3
Ajanta Pharma Q3:
Cons Net Profit At Rs.111.3 Cr Vs Rs.93 Cr (YoY)
Cons Total Income At Rs.473 Cr Vs Rs.408 Cr (YoY)
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment